Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.9 |
mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.027 | 0.9 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.015 | 0.9 |